USE OF A CD4/CD8 BISPECIFIC ANTIBODY FOR THE TREATMENT OF DIABETES

摘要

The present disclosure is directed to bispecific antibodies binding to CD4 and CD8. In a further embodiment, there is provided a method of treating diabetes in a subject comprising providing the bispecific antibodies binding to CD4 and CD8 to said subject. In some aspects, the diabetes is Type 1 diabetes. A further embodiment provides a kit comprising an antibody or antibody fragment according to the embodiments, e.g., the bispecific antibody or antibody fragment to CD4 and CD8.